US Patent Issued to United Arab Emirates University on April 21 for "Peptide inhibitors targeting methyltransfer mechanism of SARS-CoV-2" (Emirati Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,423, issued on April 21, was assigned to United Arab Emirates University (Al Ain, United Arab Emirates).

"Peptide inhibitors targeting methyltransfer mechanism of SARS-CoV-2" was invented by Abdulla Mahboob (Al Ain, United Arab Emirates).

According to the abstract* released by the U.S. Patent & Trademark Office: "Synthetic peptides mimicking the nsp10 sequence in the region interacting with nsp16 capable of penetrating cell membranes and inhibiting SARS-CoV-2 replication for the treatment of moderate to severe COVID-19. The invention relates to peptides inhibiting SARS-CoV-2 replication, likely through inhibition of Methyltransferase complexes (NSP10/NSP16 and NSP10/NSP14). The ...